Abstract
Activation of the newly identified σ1 chaperone protein is involved in several aspects of the psychostimulant and addictive effects of cocaine. The development of ligands that selectively target the σ1 protein may lead to putative potent anti-cocaine agents. We report here a new and more convergent synthetic pathway to amino side chain substituted hydantoins. Twenty new analogs of our lead compound were synthesized. None of them showed better in vitro affinity for σ1 receptor than our lead compound. Nevertheless, three of them, obtained as racemates, showed high in vitro affinity and selectivity for σ1 receptor. A preliminary in vivo evaluation of their pharmacological activity identified compound 22 as one that increases cocaine-induced locomotor stimulation and therefore acts as a potential efficient σ1 agonist.
Keywords: 1 protein, agonist, hydantoin, isoquinoline, cocaine, addiction, racemates, protein, hyperlocomotion, stereotypies, Tic-hydantoin, stereochemistry, Glennon's model, HOBt, HBTU, Thin layer chromatography, HPLC, TLC, flash chromatography, Whatman GF/B filters, ad libitum, Dunnett's post-hoc comparison test
Medicinal Chemistry
Title: New Synthesis of Tic-Hydantoins Sigma-1 Ligands and Pharmacological Evaluation on Cocaine-Induced Stimulant Effects
Volume: 6 Issue: 6
Author(s): M. Toussaint, M.-A. Debreu-Fontaine, T. Maurice and P. Melnyk
Affiliation:
Keywords: 1 protein, agonist, hydantoin, isoquinoline, cocaine, addiction, racemates, protein, hyperlocomotion, stereotypies, Tic-hydantoin, stereochemistry, Glennon's model, HOBt, HBTU, Thin layer chromatography, HPLC, TLC, flash chromatography, Whatman GF/B filters, ad libitum, Dunnett's post-hoc comparison test
Abstract: Activation of the newly identified σ1 chaperone protein is involved in several aspects of the psychostimulant and addictive effects of cocaine. The development of ligands that selectively target the σ1 protein may lead to putative potent anti-cocaine agents. We report here a new and more convergent synthetic pathway to amino side chain substituted hydantoins. Twenty new analogs of our lead compound were synthesized. None of them showed better in vitro affinity for σ1 receptor than our lead compound. Nevertheless, three of them, obtained as racemates, showed high in vitro affinity and selectivity for σ1 receptor. A preliminary in vivo evaluation of their pharmacological activity identified compound 22 as one that increases cocaine-induced locomotor stimulation and therefore acts as a potential efficient σ1 agonist.
Export Options
About this article
Cite this article as:
Toussaint M., Debreu-Fontaine M.-A., Maurice T. and Melnyk P., New Synthesis of Tic-Hydantoins Sigma-1 Ligands and Pharmacological Evaluation on Cocaine-Induced Stimulant Effects, Medicinal Chemistry 2010; 6 (6) . https://dx.doi.org/10.2174/157340610793563956
DOI https://dx.doi.org/10.2174/157340610793563956 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Current Molecular Pharmacology Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review
Current Drug Targets Retina Repair, Stem Cells and Beyond
Current Neurovascular Research Integrin Antagonists: A Special Emphasis on Structural Requirements of N-benzoyl-L-biphenylalanines as α4β7 and α4β1 Antagonists
Current Signal Transduction Therapy Pediatric Speech Perception in Noise
Current Pediatric Reviews Synthetic Sphingosine 1-Phosphate Receptor Modulators - Opportunities and Potential Pitfalls
Current Topics in Medicinal Chemistry Try to Remember: Interplay between Memory and Substance Use Disorder
Current Drug Targets The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System
Current Pharmaceutical Design Targeting Vascular Neural Network in Intracerebral Hemorrhage
Current Pharmaceutical Design What can Actigraphy Add to the Concept of Labschool Design in Clinical Trials?
Current Pharmaceutical Design Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Extracellular Release of Non-Peptide Group Compounds by Antifungal Bacillus and Brevibacillus Strains
Current Bioactive Compounds Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Pharmacology of Cell Adhesion Molecules of the Nervous System
Current Neuropharmacology Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Current Protein & Peptide Science Conceptual Issues in Psychiatric Neuroimaging: An Update
Current Topics in Medicinal Chemistry Editorial
Central Nervous System Agents in Medicinal Chemistry Study of the Effects of L-tryptophane Nanoparticles on Motor Behavior in Alzheimer's Experimental Models
CNS & Neurological Disorders - Drug Targets The Causal Relationship Between Passive Smoking and Inflammation on the Development of Cardiovascular Disease: A Review of the Evidence
Inflammation & Allergy - Drug Targets (Discontinued)